A mechanistic role for the chromatin modulator, NAP1L1, in pancreatic neuroendocrine neoplasm proliferation and metastases

被引：0
|
作者：
Simon Schimmack
Andrew Taylor
Ben Lawrence
Daniele Alaimo
Hubertus Schmitz-Winnenthal
Markus W Büchler
Irvin M Modlin
Mark Kidd
机构：
[1] Yale University School of Medicine,Gastrointestinal Pathobiology Research Group
[2] University Hospital Heidelberg,Department of General, Visceral and Transplantation Surgery
来源：
Epigenetics & Chromatin | / 7卷
关键词：
NAP1L1; Pancreatic neuroendocrine neoplasms; pNETs; Promoter methylation; p57; Proliferation;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] NAP1L1 is a prognostic biomarker and contribute to doxorubicin chemotherapy resistance in human hepatocellular carcinoma
    Le, Yong
    Kan, Anna
    Li, Qi-Jiong
    He, Min-Ke
    Chen, Hai-Long
    Shi, Ming
    CANCER CELL INTERNATIONAL, 2019, 19 (01)
  • [22] NAP1L1 promotes the growth of colon cancer by activating HDGF/DDX5
    Liang, Xuemin
    Tang, Zibo
    Zhang, Yewei
    Sun, Yihan
    Wang, Jiang
    ACTA BIOCHIMICA ET BIOPHYSICA SINICA, 2022, 54 (09) : 1234 - 1243
  • [23] NAP1L1 Regulates Hepatitis C Virus Entry and Interacts with NS3
    Peiqi Yin
    Ye Li
    Liya Zhou
    Leiliang Zhang
    Virologica Sinica, 2018, 33 (02) : 205 - 208
  • [24] Mismatch repair protein and PD-1/PD-L1 expression in pancreatic neuroendocrine neoplasm
    Duan, X. L.
    Hao, S. M.
    Zhao, M.
    Mi, L.
    Shi, J.
    Li, N.
    Yin, X. L.
    Han, X.
    Han, G. J.
    Wang, J. F.
    Li, C. Z.
    Yin, F.
    JOURNAL OF NEUROENDOCRINOLOGY, 2021, 33 : 106 - 106
  • [25] 肝细胞肝癌内NAP1L1的表达及其临床意义
    乐勇
    欧阳晗月
    张永法
    郭荣平
    石明
    实用癌症杂志, 2016, 31 (11) : 1741 - 1743
  • [26] The Role of Genetic Markers— NAP1L1, MAGE-D2, and MTA1—in Defining Small-Intestinal Carcinoid Neoplasia
    Mark Kidd
    Irvin M. Modlin
    Shrikant M. Mane
    Robert L. Camp
    Geeta Eick
    Igor Latich
    Annals of Surgical Oncology, 2006, 13 : 253 - 262
  • [27] PRDM8 exhibits antitumor activities toward hepatocellular carcinoma by targeting NAP1L1
    Chen, Zhiqiang
    Gao, Wen
    Pu, Liyong
    Zhang, Long
    Han, Guoyong
    Zuo, Xueliang
    Zhang, Yao
    Li, Xiangcheng
    Shen, Hongbing
    Wu, Jindao
    Wang, Xuehao
    HEPATOLOGY, 2018, 68 (03) : 994 - 1009
  • [28] Role of PD-L1 expression as a biomarker for GEP neuroendocrine neoplasm grading
    Cavalcanti, Elisabetta
    Armentano, Raffaele
    Valentini, Anna Maria
    Chieppa, Marcello
    Caruso, Maria Lucia
    CELL DEATH & DISEASE, 2017, 8 : e3004 - e3004
  • [29] Nucleosome assembly protein 1 like 1 (NAP1L1) promotes cardiac fibrosis by inhibiting YAP1 ubiquitination and degradation
    Li, Tianyu
    Niu, Zhihui
    Yu, Tong
    Li, Jinrui
    Lu, Xin
    Huang, Mengqin
    Wang, Qianqian
    Yu, Xiaojiang
    Feng, Jiayue
    Xu, Bingqian
    Bing, Danyang
    Li, Xuelian
    Lu, Lifang
    Liang, Haihai
    Yang, Rui
    Wang, Bin
    Shan, Hongli
    MEDCOMM, 2023, 4 (05):
  • [30] NAP1L1: A Novel Human Colorectal Cancer Biomarker Derived From Animal Models of Apc Inactivation
    Queiroz, Cleberson J. S.
    Song, Fei
    Reed, Karen R.
    Al-Khafaji, Nadeem
    Clarke, Alan R.
    Vimalachandran, Dale
    Miyajima, Fabio
    Pritchard, D. Mark
    Jenkins, John R.
    FRONTIERS IN ONCOLOGY, 2020, 10
12345